Home › Gastrointestinal Stromal Tumors › Pennsylvania › Philadelphia
Gastrointestinal Stromal Tumors clinical trials in Philadelphia, PA
6 studies for Gastrointestinal Stromal Tumors are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
RecruitingPhase 3
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Philadelphia
DESTINY-PANTUMOUR04
RecruitingObservational study
- Research Site, Philadelphia
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
RecruitingPhase 2
- Fox Chase Cancer Center, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RecruitingPhase 2
- Thomas Jefferson University, Philadelphia
A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
RecruitingPhase 1/2
- Fox Chase Cancer Center, Philadelphia
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
RecruitingPhase 1
- Thomas Jefferson University, Philadelphia
- Temple University Health System, Philadelphia
Gastrointestinal Stromal Tumors trials in other cities
- Miami, FL8 studies
- Boston, MA7 studies
- New York City, NY7 studies
- Houston, TX6 studies
- Portland, OR5 studies
- Nashville, TN5 studies
- San Diego, CA5 studies
- Omaha, NE5 studies
- Chicago, IL4 studies
- Los Angeles, CA4 studies
- Ann Arbor, MI4 studies
- Durham, NC4 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.